Arrowhead Co.

Other News To Note.
BIOWORLD Today; 11/3/2009; 1625 words; ...of Pasadena, Calif., a majority-owned subsidiary of Arrowhead Research Corp., treated the first patient in a Phase I study...of Tokyo, and in France, where Ipsen may elect to retain co-marketing rights. The exercise of the option triggered a...

Benitec Reduces Work Force By Half To Push RNAi Work.
BIOWORLD Today; 11/3/2009; 1346 words; ...with Brean Murray, Carret & Co. in New York, classed Benitec...Acuity Pharmaceuticals Inc. and Arrowhead Research Corp., of Pasadena...degeneration program with Merck & Co. Inc., of Whitehouse Station...by New York-based Needham & Co. analyst Mark Monane, after...

Vasogen Raises $16M Ahead Of Celacade Launch In Europe.
BIOWORLD Today; 11/3/2009; 1188 words; ...In other financings news: o Arrowhead Research Corp., of Pasadena...per share. Gross proceeds to Arrowhead are expected to total about...placement agent. Shares of Arrowhead (NASDAQ:ARWR) closed at...Calif., said Punk, Ziegel & Co., the underwriter of its...

Calando To Use Alnylam's RNAi Portfolio For Cancer.
BIOWORLD Today; 11/3/2009; 851 words; ...Founded as a majority-held subsidiary of Arrowhead Research Corp. in February 2005, Calando...also a majority-held subsidiary of Arrowhead. Insert's Cyclosert technology is a...Japan-based GeneCare Research Institute Co. Ltd., as well as St. Lucia, Australia...

Other News To Note.(Company overview)
BIOWORLD Today; 11/3/2009; 3764 words; ...sales of R1550. Both products are being co-developed with F. Hoffmann-La Roche...drugs that affect disease pathways. o Arrowhead Research Corp., of Pasadena, Calif...majority-owned subsidiary formed by Arrowhead, which funds university research primarily...